Holdings of Invesco Nasdaq Biotechnology ETF
Invesco Exchange-Traded Fund Trust II · Original filing · Compare with another fund · Report an error
- Net assets
- 75.7M $ including 75.6M $ in equities, 99.9 %
- Positions
- 261 in 18 countries
- Top ten
- 46.7 % of net assets
- Filed on
- Feb 28, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Gilead Sciences Inc | 48,865 | 7.3M $ | 9.61 % |
| 2 | Vertex Pharmaceuticals Inc | 14,178 | 7M $ | 9.30 % |
| 3 | Amgen Inc | 17,796 | 6.9M $ | 9.12 % |
| 4 | Regeneron Pharmaceuticals, Inc. | 5,839 | 4.6M $ | 6.03 % |
| 5 | Alnylam Pharmaceuticals Inc | 7,470 | 2.5M $ | 3.28 % |
| 6 | Insmed Inc | 12,065 | 1.8M $ | 2.38 % |
| 7 | Biogen Inc | 8,295 | 1.6M $ | 2.10 % |
| 8 | Argenx SE | 1,648 | 1.3M $ | 1.67 % |
| 9 | United Therapeutics Corp | 2,437 | 1.2M $ | 1.62 % |
| 10 | Moderna Inc | 22,109 | 1.2M $ | 1.56 % |
| 11 | Illumina Inc | 8,646 | 1.2M $ | 1.53 % |
| 12 | Roivant Sciences Ltd | 39,369 | 1.1M $ | 1.50 % |
| 13 | Incyte Corp | 11,115 | 1.1M $ | 1.49 % |
| 14 | Royalty Pharma PLC | 24,171 | 1.1M $ | 1.47 % |
| 15 | Revolution Medicines Inc | 10,938 | 1.1M $ | 1.47 % |
| 16 | Viatris Inc | 65,178 | 973.1K $ | 1.28 % |
| 17 | Ascendis Pharma A/S | 3,474 | 811.2K $ | 1.07 % |
| 18 | Neurocrine Biosciences Inc | 5,641 | 746K $ | 0.98 % |
| 19 | Ionis Pharmaceuticals Inc | 9,163 | 743.6K $ | 0.98 % |
| 20 | Sanofi SA | 14,988 | 729.3K $ | 0.96 % |
| 21 | Bridgebio Pharma Inc | 10,918 | 725.8K $ | 0.96 % |
| 22 | Medpace Holdings Inc | 1,593 | 719.7K $ | 0.95 % |
| 23 | Summit Therapeutics Inc | 42,174 | 699.7K $ | 0.92 % |
| 24 | Guardant Health Inc | 7,319 | 687.3K $ | 0.91 % |
| 25 | BioMarin Pharmaceutical Inc | 10,885 | 671.9K $ | 0.89 % |
| 26 | Exelixis Inc | 15,175 | 668.6K $ | 0.88 % |
| 27 | Jazz Pharmaceuticals PLC | 3,442 | 654K $ | 0.86 % |
| 28 | BioNTech SE | 5,726 | 631.2K $ | 0.83 % |
| 29 | BEONE MEDICINES LTD | 1,784 | 565.5K $ | 0.75 % |
| 30 | Madrigal Pharmaceuticals Inc | 1,287 | 556K $ | 0.73 % |
| 31 | ImmunityBio Inc | 55,881 | 546.5K $ | 0.72 % |
| 32 | Tempus AI Inc | 9,809 | 522.3K $ | 0.69 % |
| 33 | Arrowhead Pharmaceuticals Inc | 7,676 | 485.7K $ | 0.64 % |
| 34 | Praxis Precision Medicines Inc | 1,420 | 478.2K $ | 0.63 % |
| 35 | Axsome Therapeutics Inc | 2,849 | 466.9K $ | 0.62 % |
| 36 | Halozyme Therapeutics Inc | 6,671 | 463.8K $ | 0.61 % |
| 37 | Vaxcyte Inc | 7,425 | 458.4K $ | 0.61 % |
| 38 | Krystal Biotech Inc | 1,646 | 453.7K $ | 0.60 % |
| 39 | Cytokinetics Inc | 6,884 | 428.3K $ | 0.57 % |
| 40 | Nuvalent Inc | 4,101 | 418.1K $ | 0.55 % |
| 41 | Abivax SA | 3,337 | 404.7K $ | 0.53 % |
| 42 | Arcellx Inc | 3,276 | 372.8K $ | 0.49 % |
| 43 | Kymera Therapeutics Inc | 4,067 | 371.5K $ | 0.49 % |
| 44 | Rhythm Pharmaceuticals Inc | 3,774 | 350K $ | 0.46 % |
| 45 | Cogent Biosciences Inc | 8,738 | 339.5K $ | 0.45 % |
| 46 | Protagonist Therapeutics Inc | 3,560 | 327.8K $ | 0.43 % |
| 47 | CRISPR Therapeutics AG | 5,417 | 325.8K $ | 0.43 % |
| 48 | Caris Life Sciences Inc | 15,855 | 319.3K $ | 0.42 % |
| 49 | PTC Therapeutics Inc | 4,553 | 310.5K $ | 0.41 % |
| 50 | Alkermes PLC | 9,274 | 279.1K $ | 0.37 % |
| 51 | Immunovant Inc | 9,812 | 272.1K $ | 0.36 % |
| 52 | CG oncology Inc | 4,605 | 270.8K $ | 0.36 % |
| 53 | Mirum Pharmaceuticals Inc | 2,923 | 269.8K $ | 0.36 % |
| 54 | Scholar Rock Holding Corp | 5,710 | 252.8K $ | 0.33 % |
| 55 | Amicus Therapeutics Inc | 17,240 | 247.7K $ | 0.33 % |
| 56 | Amneal Pharmaceuticals Inc | 17,835 | 246.3K $ | 0.33 % |
| 57 | Structure Therapeutics Inc | 3,736 | 235.3K $ | 0.31 % |
| 58 | ACADIA Pharmaceuticals Inc | 9,567 | 235K $ | 0.31 % |
| 59 | Indivior Pharmaceuticals Inc | 6,991 | 228.7K $ | 0.30 % |
| 60 | Newamsterdam Pharma Co NV | 6,442 | 228.4K $ | 0.30 % |
| 61 | Crinetics Pharmaceuticals Inc | 5,407 | 222.2K $ | 0.29 % |
| 62 | Ligand Pharmaceuticals Inc | 1,101 | 218.3K $ | 0.29 % |
| 63 | Erasca Inc | 15,831 | 216.3K $ | 0.29 % |
| 64 | Apogee Therapeutics Inc | 3,075 | 215.3K $ | 0.28 % |
| 65 | Terns Pharmaceuticals Inc | 5,023 | 211.6K $ | 0.28 % |
| 66 | ADMA Biologics Inc | 13,305 | 207.2K $ | 0.27 % |
| 67 | Xenon Pharmaceuticals Inc | 4,390 | 189.8K $ | 0.25 % |
| 68 | Spyre Therapeutics Inc | 4,352 | 187.2K $ | 0.25 % |
| 69 | Arcutis Biotherapeutics Inc | 6,836 | 184.4K $ | 0.24 % |
| 70 | Edgewise Therapeutics Inc | 5,934 | 180.6K $ | 0.24 % |
| 71 | Tarsus Pharmaceuticals Inc | 2,367 | 178.8K $ | 0.24 % |
| 72 | Supernus Pharmaceuticals Inc | 3,195 | 174.9K $ | 0.23 % |
| 73 | Denali Therapeutics Inc | 8,178 | 173.2K $ | 0.23 % |
| 74 | Veracyte Inc | 4,424 | 161.9K $ | 0.21 % |
| 75 | Beam Therapeutics Inc | 5,686 | 161.8K $ | 0.21 % |
| 76 | Alumis Inc | 5,443 | 161.6K $ | 0.21 % |
| 77 | Twist Bioscience Corp | 3,416 | 160.3K $ | 0.21 % |
| 78 | Ideaya Biosciences Inc | 4,907 | 158K $ | 0.21 % |
| 79 | 10X Genomics Inc | 6,513 | 150.1K $ | 0.20 % |
| 80 | Travere Therapeutics Inc | 4,995 | 148.8K $ | 0.20 % |
| 81 | Apellis Pharmaceuticals Inc | 7,068 | 148.1K $ | 0.20 % |
| 82 | Vera Therapeutics Inc | 3,585 | 146.2K $ | 0.19 % |
| 83 | CENTESSA PHARMACEUTICALS PLC | 5,405 | 145.2K $ | 0.19 % |
| 84 | Disc Medicine Inc | 2,105 | 140.2K $ | 0.19 % |
| 85 | Adaptive Biotechnologies Corp | 8,546 | 136.9K $ | 0.18 % |
| 86 | WaVe Life Sciences Ltd | 9,352 | 130.3K $ | 0.17 % |
| 87 | Mineralys Therapeutics Inc | 4,428 | 129.6K $ | 0.17 % |
| 88 | Ultragenyx Pharmaceutical Inc | 5,405 | 126.4K $ | 0.17 % |
| 89 | Dyne Therapeutics Inc | 7,965 | 124.4K $ | 0.16 % |
| 90 | Maze Therapeutics Inc | 2,678 | 122.1K $ | 0.16 % |
| 91 | Stoke Therapeutics Inc | 3,184 | 115.9K $ | 0.15 % |
| 92 | GRAIL Inc | 2,176 | 115.8K $ | 0.15 % |
| 93 | Kiniksa Pharmaceuticals International Plc | 2,538 | 112.9K $ | 0.15 % |
| 94 | Harrow Inc | 2,072 | 112.3K $ | 0.15 % |
| 95 | Olema Pharmaceuticals Inc | 4,401 | 106.5K $ | 0.14 % |
| 96 | Ocular Therapeutix Inc | 11,885 | 106.3K $ | 0.14 % |
| 97 | Syndax Pharmaceuticals Inc | 4,873 | 105.8K $ | 0.14 % |
| 98 | Recursion Pharmaceuticals Inc | 28,735 | 105.5K $ | 0.14 % |
| 99 | Aurinia Pharmaceuticals Inc | 7,358 | 104.3K $ | 0.14 % |
| 100 | BioCryst Pharmaceuticals Inc | 11,766 | 103K $ | 0.14 % |
Sector breakdown
- Health care 53.0 %
- Unattributed 47.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 89.4 %
- Netherlands 2.2 %
- Bermuda 1.5 %
- France 1.5 %
- Ireland 1.3 %
- Denmark 1.2 %
- Germany 0.8 %
- Canada 0.6 %
- Switzerland 0.5 %
- Cayman Islands 0.3 %
- Singapore 0.2 %
- Jersey 0.1 %
- Other countries 0.4 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 225 | 67.7M $ | 89.44 % |
| 2 | Netherlands | 4 | 1.6M $ | 2.18 % |
| 3 | Bermuda | 1 | 1.1M $ | 1.51 % |
| 4 | France | 2 | 1.1M $ | 1.50 % |
| 5 | Ireland | 4 | 1M $ | 1.34 % |
| 6 | Denmark | 2 | 906.7K $ | 1.20 % |
| 7 | Germany | 1 | 631.2K $ | 0.83 % |
| 8 | Canada | 4 | 450.4K $ | 0.60 % |
| 9 | Switzerland | 2 | 342.2K $ | 0.45 % |
| 10 | Cayman Islands | 5 | 193.3K $ | 0.26 % |
| 11 | Singapore | 1 | 130.3K $ | 0.17 % |
| 12 | Jersey | 1 | 85.6K $ | 0.11 % |
Cite this page
Titelia. "Holdings of Invesco Nasdaq Biotechnology ETF". https://titelia.com/en/funds/S000072469